NOUVEL INHIBITEUR DE KINASE CONTRE UN EGFR DE TYPE SAUVAGE ET UN EGFR MUTÉ

• 收藏
• 分享

专利权人:

Ltd.;Precedo Pharmaceuticals Co.

发明人:

申请号：

EP16881172.7

公开号：

EP3398950A4

申请日:

2016.12.27

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

The present application provides a compound of Formula (I) as an inhibitor against wild-type EGFR and/or mutant EGFR, which may be used for treating human non-small cell lung cancer individually or in combination with other therapeutic agent(s). The compound of Formula (I) of the present application may be used for treating patients of drug-resistant human non-small cell lung cancer harboring wild-type EGFR and/or EGFR T790M mutation and/or EGFR L858R mutation and/or EGFR delE746_A750 mutation.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/